Immunogen | IMGN - Vermögenswerte



Vermögenswerte Veränderung Datum
AbbVie USD 133.96B 62M 2025-12
Agios Pharmaceuticals USD 1.18B 112.24M 2026-03
Amgen USD 92.5B 1.92B 2026-03
Astellas Pharma JPY 3.57T 36.87B 2026-03
AstraZeneca USD 114.02B 59M 2026-03
Bristol-Myers Squibb USD 86.48B 3.56B 2026-03
Eli Lilly USD 116.58B 4.1B 2026-03
Emergent BioSolutions USD 1.82B 69.9M 2023-12
Exelixis USD 2.84B 20.87M 2025-12
Halozyme Therapeutics USD 2.53B 304.09M 2025-12
Heron Therapeutics USD 255.88M 6.93M 2025-12
Intrexon USD 73.16M 77.88M 2024-06
Karyopharm Therapeutics USD 108.42M 12.18M 2025-12
MacroGenics USD 256.85M 13.92M 2025-12
Nektar Therapeutics USD 280.41M 20.94M 2025-12
Novartis USD 110.95B 3.66B 2025-12
Pfizer USD 207.62B 542M 2026-03
Regeneron Pharmaceuticals USD 40.87B 310.1M 2026-03
Roche Holding CHF 100.7B 5.94B 2025-12
Sanofi EUR 126.81B 25.48B 2025-12